-0.1 C
Ottawa
Tuesday, March 3, 2026

Moderna Projects Lower Revenue in 2025 Due to Flagging COVID-19 Vaccine Sales

Date:

Revenue in the third quarter was down 45 percent from the third quarter of the prior year.Moderna COVID-19 vaccine, in this file illustration image. Joe Raedle/Getty Images11/6/2025|Updated: 11/6/2025Moderna on Nov. 6 revised its revenue projections for 2025 after third-quarter sales plummeted from a year prior.Moderna made just $1 billion in the third quarter, down 45 percent from the $1.9 billion it made in the third quarter of 2024.Zachary StieberSenior ReporterZachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]Author’s Selected Articles

spot_imgspot_imgspot_img

Share post:

More like this
Related

Strikes on Iran Will Cut at the CCP: Gordon Chang

Gordon Chang, China analyst and author of "The Coming...

New Target CEO Forecasts Turnaround to Retailers Lackluster Sales in 2025

A person walks toward a Target store in Nashville,...

FDA Warns 30 Telehealth Firms Over Misleading Compounded GLP-1 Ads

Signage outside the Food and Drug Administration (FDA) headquarters...

AI Layoffs Catch up With Fintech Industry

The logo for the U.S. tech firm Block is...